Cargando…

Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases

Interleukin-1β (IL-1β) and type I interferons (IFNs) are major cytokines involved in autoinflammatory/autoimmune diseases. Separately, the overproduction of each of these cytokines is well described and constitutes the hallmark of inflammasomopathies and interferonopathies, respectively. While their...

Descripción completa

Detalles Bibliográficos
Autor principal:	Georgel, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8150590/ https://www.ncbi.nlm.nih.gov/pubmed/34066649 http://dx.doi.org/10.3390/cells10051134

Ejemplares similares

Crosstalk between Autophagy and Type I Interferon Responses in Innate Antiviral Immunity
por: Tian, Yu, et al.
Publicado: (2019)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

Interferon in systemic lupus erythematosus—A halfway between monogenic autoinflammatory and autoimmune disease
por: Saulescu, Ioana, et al.
Publicado: (2022)

Interleukin-6 inhibition in the treatment of autoinflammatory diseases
por: Koga, Tomohiro, et al.
Publicado: (2022)

Notch Signaling Regulation in Autoinflammatory Diseases
por: Gratton, Rossella, et al.
Publicado: (2020)

Crosstalk Between Autophagy and the cGAS–STING Signaling Pathway in Type I Interferon Production
por: Zhang, Kunli, et al.
Publicado: (2021)

Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review
por: Gómez-Arias, Pedro Jesús, et al.
Publicado: (2021)

Crosstalk between interferon and interleukin-1 antiviral signaling in cancer cells: implications for immune evasion and therapeutic resistance
por: Gjerstorff, Morten Frier
Publicado: (2023)

Interleukin-1 Links Autoimmune and Autoinflammatory Pathophysiology in Mixed-Pattern Psoriasis
por: Kölliker Frers, Rodolfo, et al.
Publicado: (2021)

An autoinflammatory neurological disease due to interleukin 6 hypersecretion
por: Salsano, Ettore, et al.
Publicado: (2013)

Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases
por: Bettiol, Alessandra, et al.
Publicado: (2019)

Interleukin-1-related cytokines as potential biomarkers in autoinflammatory skin diseases
por: Bonnekoh, H, et al.
Publicado: (2015)

Functional Crosstalk between Type I and II Interferon through the Regulated Expression of STAT1
por: Gough, Daniel J., et al.
Publicado: (2010)

Rare Autoinflammatory Diseases
por: Başaran, Özge, et al.
Publicado: (2022)

Macroglobulinemia and Autoinflammatory Disease
por: Navetta-Modrov, Brianne, et al.
Publicado: (2021)

Autoinflammatory diseases and the kidney
por: Hegazy, Mohamed Tharwat, et al.
Publicado: (2023)

Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome
por: Quartier, Pierre
Publicado: (2011)

Pathogenic roles and diagnostic utility of interleukin-18 in autoinflammatory diseases
por: Shimizu, Masaki, et al.
Publicado: (2022)

Elucidation of the Pathogenesis of Autoinflammatory Diseases Using iPS Cells
por: Saito, Megumu K.
Publicado: (2021)

Anti-interleukin 1 treatment in secondary renal amyloidosis associated with autoinflammatory diseases
por: Topaloglu, R, et al.
Publicado: (2015)

Autoinflammatory Diseases in Childhood
por: Yıldız, Mehmet, et al.
Publicado: (2020)

The role of type I IFN in autoimmune and autoinflammatory diseases with CNS involvement
por: Raftopoulou, Sylvia, et al.
Publicado: (2022)

Dysfunctional immunoproteasomes in autoinflammatory diseases
por: Arimochi, Hideki, et al.
Publicado: (2016)

Autoinflammatory Diseases and Physical Therapy
por: Gurcay, Eda, et al.
Publicado: (2017)

Molecular biology of autoinflammatory diseases
por: Masumoto, Junya, et al.
Publicado: (2021)

Cutaneous Manifestations of Autoinflammatory Diseases
por: Wu, Di, et al.
Publicado: (2021)

The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases
por: Gaggiano, Carla, et al.
Publicado: (2022)

Interleukin 1 inhibitors in monogenic autoinflammatory diseases – one size does not fit all
por: Więsik-Szewczyk, Ewa
Publicado: (2021)

Crosstalk between p53 and TGF-β Signalling
por: Elston, Rebecca, et al.
Publicado: (2012)

Interleukin-1 Blockade in Polygenic Autoinflammatory Disorders: Where Are We now?
por: Malcova, Hana, et al.
Publicado: (2021)

Interleukin-1 as a Common Denominator from Autoinflammatory to Autoimmune Disorders: Premises, Perils, and Perspectives
por: Lopalco, Giuseppe, et al.
Publicado: (2015)

The role of polymorphic ERAP1 in autoinflammatory disease
por: Reeves, Emma, et al.
Publicado: (2018)

Is Still's Disease an Autoinflammatory Syndrome?
por: Rossi-Semerano, Linda, et al.
Publicado: (2012)

The Expanding Spectrum of Autoinflammatory Diseases
por: Migita, Kiyoshi, et al.
Publicado: (2023)

Kidney Involvement in Autoinflammatory Diseases
por: Zhang, Changming, et al.
Publicado: (2023)

Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses
por: Mayer-Barber, Katrin D, et al.
Publicado: (2017)

Stratification of patients with autoinflammatory phenotypes by interferon (IFN) score suggests a new group of IFN mediated autoinflammatory diseases with overlapping clinical phenotypes
por: de Jesus, A Almeida, et al.
Publicado: (2015)

Interleukin-1β Signaling in Dendritic Cells Induces Antiviral Interferon Responses
por: Aarreberg, Lauren D., et al.
Publicado: (2018)

Differential Regulation of Type I and Type III Interferon Signaling
por: Stanifer, Megan L., et al.
Publicado: (2019)

Immunopathogenesis of granulomas in chronic autoinflammatory diseases
por: Timmermans, Wilhelmina Maria Cornelia, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_10eqo1pcb5dajqbi0lja5mqdq7